Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following: a) LACERATION TRAY, Model Numbe... — FDA record Z-2184-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date May 18, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Medline Probe Cover Kits containing sterile Ultrasound Gel, Labeled as the following: a) LACERATION TRAY, Model Number DYNDL1134A; b) ULTRASOUND GUIDED IV/MIDLINE K, Model Number DYNDV2385; c) PEDIATRIC CENTRAL LINE KIT, Model Number DYNJ38885B; d) CENTRAL LINE TRAY, Model Number DYNJ42902B; e) CENTRAL LINE PACK - COMPANION, Model Number DYNJ47215D; f) PICC LINEPACK (PCLUI)642-LF, Model Number DYNJ47717A; g) PK CUST CENTRAL LINE PACK, Model Number DYNJ60586; h) TUNNEL LINE PACK, Model Number DYNJ67990; i) CLOSURE PACK, Model Number DYNJ83054A
Reason
Probe covers for use during diagnostic ultrasound procedures may have an inadequate barrier at the seams.
Classification
Class II
Recalling firm
MEDLINE INDUSTRIES, LP - Northfield
Quantity
11413 units
Agency-reported status
Ongoing
Source record identifier
Z-2184-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityall lots within expiry, distributed from Medline between December 2017 - May 2023: a) Model Number DYNDL1134A, UDI/DI (EA) 10080196994762, UDI/DI (CS)40080196994763; b) Model Number DYNDV2385, UDI/DI (EA) 10193489475593, UDI/DI (CS)40193489475594; c) Model Number DYNJ38885B, UDI/DI (EA) 10193489462333, UDI/DI (CS)40193489462334; d) Model Number DYNJ42902B, UDI/DI (EA) 10888277798007, UDI/DI (CS)40888277798008; e) Model Number DYNJ47215D, UDI/DI (EA) 10888277743021, UDI/DI (CS)40888277743022; f) Model Number DYNJ47717A, UDI/DI (EA) 10193489454529, UDI/DI (CS)40193489454520; g) Model Number DYNJ60586, UDI/DI (EA) 10193489528046, UDI/DI (CS)40193489528047; h) Model Number DYNJ67990, UDI/DI (EA) 10193489462531, UDI/DI (CS)40193489462532; i) Model Number DYNJ83054A, UDI/DI (EA) 10195327310516, UDI/DI (CS)40195327310517

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Worldwide Distribution: US (Nationwide) and OUS (foreign) United Arab Emirates, Singapore, Lebanon, China Qatar, Costa Rica, India, Canada, Panama & Saudi Arabia.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 26, 2023
Recall initiation date
May 18, 2023
Center classification date
Jul 20, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records